Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease Reply

被引：0
|
作者：
Yeoh, Aaron [1 ]
Cheung, Ramsey [1 ,2 ]
Ahmed, Aijaz [1 ]
Chitnis, Amit S. [3 ]
Do, Albert [4 ]
Wong, Robert J. [1 ,2 ]
机构：
[1] Stanford, Dept Med, Div Gastroenterol, Palo Alto, CA 94304 USA
[2] Vet Affairs Palo Alto Hlth Care Syst, Gastroenterol Sect, Palo Alto, CA USA
[3] Alameda Cty Publ Hlth Dept, Div Communicable Dis Control & Prevent, TB Sect, San Leandro, CA USA
[4] Yale, Dept Med, Div Digest Dis, New Haven, CT USA
来源：
AMERICAN JOURNAL OF MEDICINE | 2024年 / 137卷 / 01期
关键词：
D O I：
10.1016/j.amjmed.2023.08.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E15 / E15
页数：1
相关论文
共 50 条
  • [41] Statins in Metabolic Dysfunction-Associated Liver Disease: Hope, Hurdles, and Biostatistical Hazards
    Kimer, Nina
    Tapper, Elliot B.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (02)
  • [42] Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
    Lim, Soo
    Kim, Jin-Wook
    Targher, Giovanni
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (07): : 500 - 514
  • [43] Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review
    Sanyal, Arun J.
    Husain, Mansoor
    Diab, Crystel
    Mangla, Kamal Kant
    Shoeb, Ahsan
    Lingvay, Ildiko
    Tapper, Elliot B.
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2024, 41
  • [44] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
  • [45] Metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease: Which can better identify the populations with a high risk of cardiovascular disease?
    Yoshio, Sachiyo
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1097 - 1099
  • [46] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Maurice Michel
    Christian Labenz
    Angelo Armandi
    Leonard Kaps
    Wolfgang Maximilian Kremer
    Peter R. Galle
    Daniel Grimm
    Martin Sprinzl
    Jörn M. Schattenberg
    Scientific Reports, 13
  • [47] Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease
    Hwang, Tae-In
    Han, A-Lum
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (24)
  • [48] Updates in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Children
    Rupasinghe, Kushila
    Hind, Jonathan
    Hegarty, Robert
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (05): : 583 - 591
  • [49] Are dairy products the answer to metabolic dysfunction-associated fatty liver disease?
    Lau, Kristopher Cho-Hei
    Wong, Vincent Wai-Sun
    HEPATOLOGY INTERNATIONAL, 2024, 18 (03) : 870 - 872
  • [50] The Relationship Between Ferroptosis and Metabolic Dysfunction-Associated Fatty Liver Disease
    Chen, Ke-qian
    Wang, Shu-zhi
    Lei, Hai-bo
    Liu, Xiang
    LIVER INTERNATIONAL, 2025, 45 (04)
12345